A Secondary Analysis of the TRIUMPH Trial
There is a recent increase in fixed-dose combination (FDCs) treatment for the initial or early management of hypertensive patients. The association of FDCs in...
There is a recent increase in fixed-dose combination (FDCs) treatment for the initial or early management of hypertensive patients. The association of FDCs in...
In 2017 guidelines from the American College of Cardiology/American Heart Association Blood Pressure Treatment, hypertension is defined with a systolic blood pressure of 130...
Thrombus formation is associated with Atherosclerotic Cardiovascular Diseases (ASCVD) namely acute coronary syndrome (ACS), ischemic heart disease (IHD), peripheral arterial disease (PAD), and ischemic...
Increasing age and atrial fibrillation are independent risk factors for stroke. In earlier trials, the mean or median age was 70 -73 years in...
The administration of Sodium-glucose co-transporter-2 (SGLT2) inhibition was shown to reduce the composite endpoint of cardiovascular deaths or hospitalization for heart failure in patients...